학술논문
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC
Document Type
Article
Author
Source
In: New England Journal of Medicine . (New England Journal of Medicine, 16 November 2023, 389(20):1839-1850)
Subject
Language
English
ISSN
15334406
00284793
00284793